Related Experiment Video
Updated: Apr 7, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.2K
All-Purpose Containers? Lipid-Binding Protein - Drug Interactions.
Tiziana Beringhelli1, Elisabetta Gianazza2, Daniela Maggioni1
1Dipartimento di Chimica, via Golgi 19, I-20133 Milano, Italy.
Plos One
|July 14, 2015
Summary
Human calycins bind to drugs like vastatins and steroids. This protein-drug interaction, particularly with atorvastatin, has implications for drug delivery and tissue accumulation.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- Calcyins are a family of lipid-binding proteins found in various human tissues.
- Understanding protein-drug interactions is crucial for optimizing drug efficacy and safety.
Purpose of the Study:
- To investigate the binding affinity of human calycins for various drugs, including steroids and vastatins.
- To elucidate the molecular features governing these protein-drug interactions.
- To explore the potential biological and pharmacokinetic implications of calycin-drug binding.
Main Methods:
- In vitro studies using 19F-NMR spectroscopy to assess binding.
- In silico molecular docking simulations to predict binding modes and affinities.
- Comparative analysis of dissociation constants (Ki) for different protein-drug complexes.
Main Results:
- Human calycins exhibit significant affinity for several drugs, notably vastatins and steroids.
- Key interaction features include the non-polar nature of drugs and specific amino acid residues within the calycin binding pocket.
- Vastatins, particularly atorvastatin, showed the strongest interactions across various conditions.
- Observed binding affinities are comparable to those of natural ligands and, in some cases, approach therapeutic drug concentrations (Cmax).
Conclusions:
- Human calycins can bind to commonly prescribed drugs, potentially influencing their distribution and accumulation in tissues.
- These findings highlight the importance of considering calycin interactions in drug delivery strategies.
- Further research is warranted to fully understand the in vivo consequences of these interactions.
Related Concept Videos
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
713
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
713
01:30Drug Binding to Blood Components
651
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
651
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
630
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
630
01:16Protein-Drug Binding: Mechanism and Kinetics
2.1K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.1K
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
675
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
675
01:25Pharmacokinetics: Drug–Drug Interactions
705
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
705